These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 11226692

  • 1. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis.
    Devine DP, Watson SJ, Akil H.
    Neuroscience; 2001; 102(3):541-53. PubMed ID: 11226692
    [Abstract] [Full Text] [Related]

  • 2. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD, Harbuz MS, Jessop DS, Fulford AJ.
    Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820
    [Abstract] [Full Text] [Related]

  • 3. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
    Leggett JD, Jessop DS, Fulford AJ.
    Neuroscience; 2007 Jul 13; 147(3):757-64. PubMed ID: 17574767
    [Abstract] [Full Text] [Related]

  • 4. Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation.
    Green MK, Barbieri EV, Brown BD, Chen KW, Devine DP.
    Neuropeptides; 2007 Dec 13; 41(6):399-410. PubMed ID: 17980908
    [Abstract] [Full Text] [Related]

  • 5. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety.
    Fernandez F, Misilmeri MA, Felger JC, Devine DP.
    Neuropsychopharmacology; 2004 Jan 13; 29(1):59-71. PubMed ID: 14532912
    [Abstract] [Full Text] [Related]

  • 6. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
    Delaney G, Dawe KL, Hogan R, Hunjan T, Roper J, Hazell G, Lolait SJ, Fulford AJ.
    J Neuroendocrinol; 2012 Dec 13; 24(12):1527-41. PubMed ID: 22835008
    [Abstract] [Full Text] [Related]

  • 7. Central corticotropin-releasing hormone receptors modulate hypothalamic-pituitary-adrenocortical and sympathoadrenal activity during stress.
    Jezova D, Ochedalski T, Glickman M, Kiss A, Aguilera G.
    Neuroscience; 1999 Dec 13; 94(3):797-802. PubMed ID: 10579570
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.
    Leggett JD, Dawe KL, Jessop DS, Fulford AJ.
    J Neuroendocrinol; 2009 Nov 13; 21(11):888-97. PubMed ID: 19732291
    [Abstract] [Full Text] [Related]

  • 11. Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress.
    Devine DP, Hoversten MT, Ueda Y, Akil H.
    J Neuroendocrinol; 2003 Jan 13; 15(1):69-74. PubMed ID: 12535171
    [Abstract] [Full Text] [Related]

  • 12. C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6).
    Kotlińska J, Suder P, Sciubisz A, Łegowska A, Eilmes J, Rolka K, Silberring J.
    Eur J Pharmacol; 2001 May 04; 419(1):33-7. PubMed ID: 11348627
    [Abstract] [Full Text] [Related]

  • 13. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats.
    Sandin J, Georgieva J, Schött PA, Ogren SO, Terenius L.
    Eur J Neurosci; 1997 Jan 04; 9(1):194-7. PubMed ID: 9042583
    [Abstract] [Full Text] [Related]

  • 14. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C, Iyer V, Bhatnagar S.
    J Neuroendocrinol; 2007 Mar 04; 19(3):198-207. PubMed ID: 17280593
    [Abstract] [Full Text] [Related]

  • 15. Neuroimmunological effects of exposure to methylmercury forms in the Sprague-Dawley rats. Activation of the hypothalamic-pituitary-adrenal axis and lymphocyte responsiveness.
    Ortega HG, Lopez M, Takaki A, Huang QH, Arimura A, Salvaggio JE.
    Toxicol Ind Health; 1997 Mar 04; 13(1):57-66. PubMed ID: 9098950
    [Abstract] [Full Text] [Related]

  • 16. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
    Ochedalski T, Subburaju S, Wynn PC, Aguilera G.
    J Neuroendocrinol; 2007 Mar 04; 19(3):189-97. PubMed ID: 17280592
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glucocorticoids are involved in the long-term effects of a single immobilization stress on the hypothalamic-pituitary-adrenal axis.
    Dal-Zotto S, Martí O, Armario A.
    Psychoneuroendocrinology; 2003 Nov 04; 28(8):992-1009. PubMed ID: 14529704
    [Abstract] [Full Text] [Related]

  • 19. Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats.
    Finn DP, Hudson AL, Kinoshita H, Coventry TL, Jessop DS, Nutt DJ, Harbuz MS.
    J Psychopharmacol; 2004 Mar 04; 18(1):47-53. PubMed ID: 15107184
    [Abstract] [Full Text] [Related]

  • 20. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection.
    Le Cudennec C, Naudin B, Do Rego JC, Costentin J.
    Life Sci; 2002 Nov 29; 72(2):163-71. PubMed ID: 12417250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.